History has shown that extreme stock market volatility often triggers a wave of unsolicited or hostile M&A activity and stockholder activism. Since March of this year, there has been a surge of companies adopting and publicly announcing shareholder rights plans (“poison pills”) to protect stockholders from such predatory activities. Should you be considering the same strategy? 

Join Mintz and Stifel for a webinar discussion that will address a number of strategic and tactical business, legal, and investment-related considerations, including:

• Lessons learned from the 2020 proxy season and recent wave of poison pill adoptions — mistakes made and winning decisions

• Understanding the modern, evolving role of the poison pill within a broader activism and takeover defense strategy

• Managing internal discussions to drive smart decisions and mechanics for implementing rights plans